Metraipolis › archive › dc_77f751b64a83

Antibody drugs conjugates in non-small cell lung cancer: current status and challenges — Europe PMC PMID:41052301

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41052301
DOI
10.1093/oncolo/oyaf331
License (as archived)
solo-consultazione
Archived
2026-11-08T21:31:33.135Z
SHA-256 of the archived text
a084ea0e34eede86cbf24e13d3204a3005356f098a60570c3f8f969d45656d86
Stable URL of this page
https://metraipolis.com/documento/dc_77f751b64a83

How to cite

Antibody drugs conjugates in non-small cell lung cancer: current status and challenges — Europe PMC PMID:41052301 — Europe PMC (en), https://europepmc.org/article/MED/41052301 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_77f751b64a83 (Metraipolis archive dc_77f751b64a83, sha256 a084ea0e34eede86cbf24e13d3204a3005356f098a60570c3f8f969d45656d86)
BibTeX
@misc{dc77f751b64a83,
  title = {Antibody drugs conjugates in non-small cell lung cancer: current status and challenges — Europe PMC PMID:41052301},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41052301},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_77f751b64a83; sha256 a084ea0e34eede86cbf24e13d3204a3005356f098a60570c3f8f969d45656d86},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41052301. Agents can read the archived copy with the MCP tool read_document.